Comparison of Frequency of Use of Optive and Systane
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this study is subjectively compare duration of action between Optive and Systane.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2006
CompletedFirst Posted
Study publicly available on registry
December 4, 2006
CompletedJune 1, 2007
May 1, 2007
November 30, 2006
May 30, 2007
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Males or females \> 18 years old
- Mild to moderate dry eye symptoms
- Score of at least 2 and no more than 4 on the SESOD at the initial screening visit
- Likely to complete all study visits and able to provide informed consent
You may not qualify if:
- Current use of topical cyclosporine
- Known contraindications to any study medication or ingredients
- Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are actively being treated or disease that is uncontrollable)
- Ocular surgery within the past 3 months,
- Active ocular allergies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Private Practice
Azusa, California, 91702, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Milton Hom, OD
Private Practice
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
November 30, 2006
First Posted
December 4, 2006
Last Updated
June 1, 2007
Record last verified: 2007-05